Review of treatment modalities in the management of Genital Warts
Review of treatment modalities in the management of Genital Warts
DOI:
https://doi.org/10.66344/jpad.32.4.2022.1992Abstract
Genital wart is one of the most commonly found human mucosal viral infection caused by the Human Papillomavirus (HPV). Genital warts can present as papules, plaques or blisters that look like a pink, brown cauliflower, or flesh-coloured mass. The treatment modalities for genital warts that are currently available are focused on eliminating the genital warts growth instead of addressing and controlling the underlying HPV infection. A little evidence has been provided regarding the existing treatment modalities in terms of their effectiveness in eliminating genital warts in the long term or that they have a key role in the prevention and development of malignant genital warts. Moreover, the treatment modalities that are currently used are different in terms of price, side effects, dosing regimen, treatment duration, and efficiency for managing genital warts. However, it is important to consider that the treatment modalities are often tailored to each patient depending on the level of HPV spread, areas that have been infected, and other comorbid chronic diseasesDownloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.